TY  - JOUR
T1  - TO battle deadly infections, clinicians draw on both new and old tools
AU  - Kuehn BM
Y1  - 2012/10/10
N1  - 10.1001/jama.2012.12574
JO  - JAMA
SP  - 1417
EP  - 1418
VL  - 308
IS  - 14
N2  - 
In some areas, such as New York, physicians now regularly battle such carbapenem-resistant Enterobacteriaceae (CRE) infections. Because effective treatment options are limited, serious infections are associated with death rates as high as 40%. Fortunately, most US hospitals have yet to see CRE infections, with only about 6% of hospitals across the country having encountered a case, according to CDC estimates. This means there's still an opportunity to prevent the spread of this type of infection before it becomes endemic at all facilities, as methicillin-resistant Staphylococcus aureus (MRSA) has, said Abbigail Tumpey, MPH, associate director for communications science in the CDC's Division of Healthcare Quality Promotion.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.12574
UR  - http://dx.doi.org/10.1001/jama.2012.12574
ER  -